On the basis of analyses performed 8 to 10 years ago, hospital costs for percutaneous transluminal angioplasty were believed to be no more than one third those of bypass.
Given increasing awareness of cost as an important component in management decisions, updated information is needed.
From 1985 to 1991, clinical and hospital cost data were collected prospectively for 255 admissions for femoropopliteal bypass and 82 for femoropopliteal angioplasty.
Mean hospital costs and length of stay per admission were calculated for subgroups of patients defined by procedure and indication, and multiple regression analysis was performed.
Mots-clés Pascal : Artériopathie oblitérante, Artère fémorale, Artère poplitée, Chirurgie, Revascularisation, Hospitalisation, Analyse coût, Homme, Etats Unis, Amérique du Nord, Amérique, Appareil circulatoire pathologie, Vaisseau sanguin pathologie, Artère pathologie, Economie santé
Mots-clés Pascal anglais : Arterial occlusive disease, Femoral artery, Popliteal artery, Surgery, Revascularization, Hospitalization, Cost analysis, Human, United States, North America, America, Cardiovascular disease, Vascular disease, Arteriopathy, Health economy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0345690
Code Inist : 002B25F. Création : 199406.